• PMS51 GABAPENTIN, OPIOID, AND BENZODIAZEPINE PRESCRIBING IN EARLY CARE OF INDIVIDUALS WITH CHRONIC BACK PAIN: A SECULAR TRENDS ANALYSIS

    May 1, 2020, 00:00 AM

  • PIH29 ECONOMIC BURDEN OF ENDOMETRIOSIS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • Cardiovascular Disorders - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • PMU26 COST-UTILITY ANALYSIS OF CANCER AND NON-CANCER CONDITIONS: A SYSTEMATIC REVIEW OF DIFFERENT LEVELS OF DISEASE PREVENTION AND CONTROL, 1990 TO 2016

    May 1, 2020, 00:00 AM

  • PDB73 EPIDEMIOLOGICAL DISEASE BURDEN OF DIABETIC POLYNEUROPATHY BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PIN78 CHARACTERIZATION OF UNNECESSARY EMERGENCY DEPARTMENT ENCOUNTERS FOR RABIES POSTEXPOSURE PROPHYLAXIS VACCINATION

    May 1, 2020, 00:00 AM

  • PIH8 UNDERSTANDING THE ECONOMIC BURDEN OF COMORBIDITIES ASSOCIATED WITH MALE HYPOGONADISM: A COST MODEL IN ENGLAND

    May 1, 2020, 00:00 AM

  • PBI2 EFFICACY AND SAFETY OF BIOLOGICS FOR THE TREATMENT OF ADULT PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN RUSSIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PDG46 OUTPATIENT OFF-LABEL GABAPENTIN UTILIZATION FROM 2011 TO 2015 AMONG UNITED STATES ADULTS

    May 1, 2020, 00:00 AM

  • PMH34 INTEGRATING COUNTY-LEVEL HEALTH, HUMAN SERVICES, AND CRIMINAL JUSTICE DATA TO PREDICT RISK OF OPIOID OVERDOSE AMONG MEDICAID BENEFICIARIES: A MACHINE LEARNING APPROACH

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • PDB55 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PMU3 EFFECTIVENESS OF IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN INDIA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PGI13 A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR THE MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PMH70 OVERVIEW OF INDIVIDUALS WITH ANXIETY DISORDERS IN THE U.S. AND TREATMENT PATTERNS IN ANTI-ANXIETY MEDICATION REGIMENS.

    May 1, 2020, 00:00 AM

  • AI2 PREDICTORS OF PARKINSON DISEASE IN A MEDICARE POPULATION: AN APPLICATION OF MACHINE LEARNING IN EARLY DISEASE DETECTION

    May 1, 2020, 00:00 AM

  • PGI16 BREAKDOWN OF COSTS ATTRIBUTABLE TO CLOSTRIDIOIDES DIFFICILE INFECTION IN THE US: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • PDG24 OPIOID-RELATED OVERDOSE IN PATIENTS WITH CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINES: A NESTED CASE-CONTROL STUDY OF COMMERCIALLY INSURED PATIENTS

    May 1, 2020, 00:00 AM

  • PMU43 ASSOCIATION BETWEEN ATOPIC DISEASES AND ANEMIA IN KOREAN PATIENTS

    May 1, 2020, 00:00 AM

  • Gastrointestinal Disorders - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • PMH39 ECONOMIC BURDEN ASSOCIATED WITH MAJOR DEPRESSIVE DISORDER, GLOBAL ANXIETY DISORDER, AND POLY-NONCOMMUNICABLE CHRONIC DISEASE (NCCD) COMORBIDITY

    May 1, 2020, 00:00 AM

  • PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

    May 1, 2020, 00:00 AM

  • PBI18 BIOLOGIC THERAPIES FOR MODERATE-TO-SEVERE PSORIASIS: COST PER RESPONDER ANALYSIS CONSIDERING PRIVATE HEALTHCARE SYSTEM IN BRAZIL

    May 1, 2020, 00:00 AM

  • PIN7 REAL-WORLD EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS (DAA) IN YOUNG ADULT (18-25) AND ELDERLY (80+) POPULATIONS WITH HEPATITIS C (HCV)

    May 1, 2020, 00:00 AM

  • PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

    May 1, 2020, 00:00 AM

  • Comparative Effectiveness Studies Methods

    May 1, 2020, 00:00 AM

  • Alternative Medicine Public Health

    May 1, 2020, 00:00 AM

  • PAM11 DEVELOPMENT AND EVALUATION OF THE BLOOD DEFICIENCY QUESTIONNAIRE (BDQ)

    May 1, 2020, 00:00 AM

  • PDB23 EXLORATION IN HEALTHCARE RESOURCE UTILIZATION (HCRU) STUDY USING EMR DATABASE AND CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMD22 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MECHANICAL THROMBECTOMY WITH STENT RETRIEVERS AFTER THROMBOLYSIS IN ISCHEMIC-STROKE WITH LARGE VESSEL OCCLUSION IN THE CHILEAN PUBLIC SECTOR.

    May 1, 2020, 00:00 AM

  • PDB11 THE PERINATAL OUTCOMES AMONG WOMEN WITH TWIN PREGNANCIES: PROPENSITY SCORE MATCHED ANALYSIS FROM A SEVEN-YEAR RETROSPECTIVE COHORT

    May 1, 2020, 00:00 AM

  • PDB4 SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF THE EFFECT OF NALTREXONE/ BUPROPION COMPARED WITH OTHER ANTI-OBESITY DRUGS IN OVERWEIGHT AND OBESE PATIENTS

    May 1, 2020, 00:00 AM

  • PDG6 HEALTH JUDICIALIZATION IN BRAZIL: IMPACT OF MIGLUSTATE MEDICINE OBLIGATION FOR PATIENTS WITHOUT OFFICIAL INDICATION OF USE, IN 2019 IN BRAZIL

    May 1, 2020, 00:00 AM

  • PCN14 UPDATED NETWORK META-ANALYSIS OF FIRST-LINE EGFR-TARGETED TYROSINE KINASE INHIBITOR TREATMENTS FOR LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR-ACTIVATING MUTATIONS

    May 1, 2020, 00:00 AM

  • PIH59 ADHERENCE TO TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PDG48 PRESCRIBING PRACTICES FOR HYPERLIPIDEMIA AMONG U.S. AMBULATORY PATIENTS

    May 1, 2020, 00:00 AM

  • PGI20 THE IMPACT OF ULCERATIVE COLITIS ON WORK PRODUCTIVITY: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • Alternative Medicine Statistical Research

    May 1, 2020, 00:00 AM

  • PDB46 ELEVATED ANNUAL HEALTHCARE UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH DIABETES MELLITUS PATIENTS WITH OSTEOPOROSIS IN CHINA

    May 1, 2020, 00:00 AM

  • PDG51 PREVALENCE AND RELATIVE PREDICTIVE VALUE OF DEMOGRAPHIC AND PAIN CHARACTERISTICS FOR OPIOID USE AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER ADULTS WITH PAIN IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PDB47 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00 AM

  • PDG33 CHANGES IN SCHEDULE II ORAL OPIOID VOLUME DISPENSED IN A PRIVATE PAYER FOLLOWING FLORIDA’S ACUTE PAIN OPIOID RESTRICTION LAW

    May 1, 2020, 00:00 AM

  • PIH72 PRENATAL MATERNAL STRESS CAN BE REDUCED BY MINDFULNESS TRAINING

    May 1, 2020, 00:00 AM

  • PMS75 PATIENT- AND PHYSICIAN-IDENTIFIED FACTORS GUIDING TREATMENT CHOICE IN KNEE OSTEOARTHRITIS AND PATIENT PREFERENCE FOR INTRA-ARTICULAR THERAPY

    May 1, 2020, 00:00 AM

  • Cardiovascular Disorders - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PMS19 A SYSTEMATIC REVIEW OF ECONOMIC MODELS FOR COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION FOLLOWING TOTAL KNEE AND HIP REPLACEMENT

    May 1, 2020, 00:00 AM

  • PIH66 ASSOCIATION BETWEEN MEDICATION BURDEN AND ADHD MEDICATION ADHERENCE IN A PEDIATRIC POPULATION WITH MULTIPLE CHRONIC CONDITIONS

    May 1, 2020, 00:00 AM

  • Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

    May 1, 2020, 00:00 AM

  • PMU60 DO COMPANIES SEQUENCE THE LAUNCH OF INDICATIONS FOR MULTI-INDICATION PRODUCTS?

    May 1, 2020, 00:00 AM

  • PCV86 EXAMINING PREDICTORS OF DURATION OF INITIAL ANTIHYPERTENSIVE THERAPY

    May 1, 2020, 00:00 AM

  • PMH67 CAPTURING PATIENT EXPERIENCE AS A KEY TO BETTER OUTCOMES: THE IMPORTANCE OF COGNITIVE APPRAISAL PROCESSES IN ENABLING RESILIENCE AMONG DEPRESSED INDIVIDUALS

    May 1, 2020, 00:00 AM

  • PDB107 ASSESSING ASYMMETRICAL PRESCRIBING OF ANTIDIABETIC DRUGS RELATIVE TO DIAGNOSIS OF NAFLD

    May 1, 2020, 00:00 AM

  • PMS65 A VISUAL ANALYTICAL APPROACH TO UNDERSTANDING TREATMENT PATTERNS AMONG TREATMENT-NAÏVE RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGIC USE IN THE US VETERANS HEALTH ADMINISTRATION DATABASE

    May 1, 2020, 00:00 AM

  • PDB66 DEFINING DIABETES MELLITUS USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMH59 COMPLEX EXAMINATION OF THE MENTAL HEALTH OF TEACHERS

    May 1, 2020, 00:00 AM

  • PDB63 MULTIMORBIDTY AND FIVE-YEAR TREND IN DIABETES CARE MANAGEMENT (DCM) AMONG ADULTS WITH DIABETES

    May 1, 2020, 00:00 AM

  • PIN87 PATIENT ENGAGEMENT IN HIV CARE MANAGEMENT: BEHAVIOR ECONOMICS OF ART ADHERENCE AND ESTABLISHING CARE VISITS

    May 1, 2020, 00:00 AM

  • PMU30 COST-EFFECTIVENESS ANALYSIS OF NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY (SMA) IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PMU28 CLINICAL AND ECONOMIC OUTCOMES OF CARBAPENEM-RESISTANT GRAM-NEGATIVE ORGANISMS: A MULTICENTER STUDY IN CHINA

    May 1, 2020, 00:00 AM

  • Medical Devices - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • Competing Views on the English EQ-5D-5L Valuation Set [Editor's Choice]

    May 1, 2020, 00:00 AM

  • PBI17 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF RITUXIMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PMH45 DISPARITIES IN TREATMENT ADMISSIONS FOR OPIOID USE DISORDER IN CINCINNATI BY RACE

    May 1, 2020, 00:00 AM

  • PCV84 BASELINE CHARACTERISTICS OF HEARTH FAILURE PATIENTS IN A PRIVATE PROVIDER IN CHILE

    May 1, 2020, 00:00 AM

  • PCV57 THE BURDEN OF HEART FAILURE IN NORTH AMERICA AND WESTERN EUROPE

    May 1, 2020, 00:00 AM

  • PIH45 COST-EFFECTIVENESS OF A CARE PUBLIC PROGRAM FOR PREGNANT WOMEN WHO HAD THEIR DELIVERY IN A THIRD - LEVEL - COMPLEXITY HOSPITAL AT COLOMBIA

    May 1, 2020, 00:00 AM

  • PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE

    May 1, 2020, 00:00 AM

  • PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE

    May 1, 2020, 00:00 AM

  • PMD47 THE CHOICES COMPARATIVE TRIAL: FACILITY COST AND OUTCOMES ANALYSIS OF MYOMECTOMY COMPARED TO TREATMENT WITH THE SONATA SYSTEM

    May 1, 2020, 00:00 AM

  • PIH71 RISK FACTORS ASSOCIATED WITH FALLS AMONG THE ELDERLY IN U.S.: AN ANALYSIS OF MEDICARE CURRENT BENEFICIARY SURVEY DATA

    May 1, 2020, 00:00 AM

  • PMH63 HUMANISTIC BURDEN ASSOCIATED WITH MAJOR DEPRESSIVE DISORDER AND GLOBAL ANXIETY DISORDER AMONG ADULTS WITH NON-COMMUNICABLE DISEASES (NCCDS) IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIN5 PREVALENCE OF DRUG RESISTANCE IN NUCLEOSIDE/NUCLEOTIDE ANALOGUE-TREATED EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B VIRUS

    May 1, 2020, 00:00 AM

  • PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00 AM

  • PMS61 DISABILITY AND DEPRESSION IN LOW BACK PAIN. EVIDENCE FROM A COHORT STUDY

    May 1, 2020, 00:00 AM

  • PIH43 SEXUAL BEHAVIOR, USE OF CONTRACEPTIVE METHODS AND PREGNANCY IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A HEALTH INSURER COMPANY IN COLOMBIA 2018

    May 1, 2020, 00:00 AM

  • PDG50 COMMUNICATION BETWEEN PATIENTS AND HEALTH CARE PROFESSIONALS ABOUT OPIOID MEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PIH69 THE NEED FOR PERSON-CENTRED CARE IN ENDOMETRIOSIS TREATMENT: QUALITATIVE INSIGHTS AND DISCRETE CHOICE EXPERIMENT DEVELOPMENT

    May 1, 2020, 00:00 AM

  • PMD34 DEEP JOINT INFECTION COMPARISON BETWEEN SIMULTANEOUS AND STAGED BILATERAL TOTAL KNEE ARTHROPLASTY

    May 1, 2020, 00:00 AM

  • PIT4 ECONOMIC BURDEN OF HOSPITALIZATIONS RELATED TO MAJOR AND MEDIUM BURN INJURIES IN BRAZIL

    May 1, 2020, 00:00 AM

  • PDB104 OPTIMIZATION OF INSULIN DOSE IN HOSPITALIZED PATIENTS WITH RECURRENT HYPOGLYCEMIA: REAL WORLD EXPERIENCE

    May 1, 2020, 00:00 AM

  • PMU52 CLINICAL ADOPTION OF GENOMIC TESTING IN ONCOLOGY: A TARGETED LITERATURE REVIEW OF THE GLOBAL PAYER LANDSCAPE

    May 1, 2020, 00:00 AM

  • PDB18 ASSESSMENT OF THE HEALTH CARE UTILIZATION AND ECONOMIC BURDEN ON DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE US VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00 AM

  • PCV60 PREVALENCE, RISK FACTORS, AND MANAGEMENT OF UNCONTROLLED HYPERTENSION AMONG DIABETIC PATIENTS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY

    May 1, 2020, 00:00 AM

  • Drugs Regulatory

    May 1, 2020, 00:00 AM

  • PMD53 COMPARISON OF WOUND CLOSURE IN SURGICAL WOUNDS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00 AM

  • Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 Trials

    May 1, 2020, 00:00 AM

  • PMH10 DETERMINANTS, TRENDS, AND COSTS ASSOCIATED WITH 30-DAY ALL-CAUSE READMISSION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH SUICIDAL IDEATION USING THE NATIONWIDE READMISSION DATABASE

    May 1, 2020, 00:00 AM

  • PDB99 BASELINE CHARACTERISTICS OF ENDOMETRIOSIS PATIENTS PARTICIPATING IN A REAL WORLD PROSPECTIVE COHORT STUDY: AN INTERIM ANALYSIS OF THE ELAGOLIX LONGITUDINAL OUTCOMES (LOTUS) STUDY

    May 1, 2020, 00:00 AM

  • PDB65 EPIDEMIOLOGICAL DISEASE BURDEN OF NON-INSULIN-DEPENDENT DIABETES WITH COMPLICATIONS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMH60 SURVEY OF PATIENT EXPERIENCE AND BURDEN OF ILLNESS IN WOMEN WITH POSTPARTUM DEPRESSION

    May 1, 2020, 00:00 AM

  • Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects

    May 1, 2020, 00:00 AM

  • PDB9 THE COMPARATIVE EFFICACY OF ORAL SEMAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA)

    May 1, 2020, 00:00 AM

  • PMH23 ECONOMIC BURDEN OF SCHIZOPHRENIA AMONG YOUNG ADULTS WITH MEDICAID COVERAGE

    May 1, 2020, 00:00 AM

  • PBI31 MANAGED ENTRY AGREEMENTS FOR ATMPS DESPITE ACCESS ALREADY GRANTED? THE CASE OF GERMANY

    May 1, 2020, 00:00 AM

  • PIH24 A CLINICAL AND ECONOMIC EVALUATION OF SURFACTANT THERAPY FOR MECONIUM ASPIRATION SYNDROME IN THE NEONATAL INTENSIVE CARE SETTING IN QATAR

    May 1, 2020, 00:00 AM

  • PMD24 ANALYSIS OF THE COST-EFFECTIVENESS OF THE LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM AS ALTERNATIVE TO HISTERECTOMIES IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00 AM

  • PMD30 HETEROGENEITY OF PATIENTS TREATED WITH MULTI-PLANAR SOFTWARE-ASSISTED EXTERNAL FIXATION SYSTEMS (SPATIAL FRAMES) - ANALYSES OF PATIENT VARIABILITY AND OPERATIVE COMPLICATIONS

    May 1, 2020, 00:00 AM

  • PDB95 FACTORS ASSOCIATED WITH MEDICATION NON-ADHERENCE AMONG MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PDB14 HYPOTHERMICALLY STORED HUMAN AMNIOTIC MEMBRANE (HSAM) FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS

    May 1, 2020, 00:00 AM

  • PBI32 EVOLUTION OF THE COST OF MEDICINES ACQUIRED BY THE COSTA RICAN SOCIAL SECURITY SYSTEM (CCSS) ACCORDINGLY TO ITS ORIGIN: BIOLOGICAL OR CHEMICAL SYNTHESIS

    May 1, 2020, 00:00 AM

  • PCV76 IDENTIFYING KNOWLEDGE GAPS IN HEART FAILURE (HF) RESEARCH AMONG WOMEN USING UNSUPERVISED MACHINE LEARNING METHODS

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Medical Technologies

    May 1, 2020, 00:00 AM

  • PMS57 EPIDEMIOLOGIC MODELING TO GUIDE PAYER DECISIONS IN RARE DISEASES: A CASE STUDY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • Individual's Health - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling

    May 1, 2020, 00:00 AM

  • PMD15 ASSESSMENT OF THE RISK AND ECONOMIC BURDEN OF SURGICAL SITE INFECTION FOLLOWING COLORECTAL SURGERY USING A US LONGITUDINAL DATABASE: IS THERE A ROLE FOR INNOVATIVE ANTIMICROBIAL WOUND CLOSURE TECHNOLOGY TO REDUCE THE RISK OF INFECTION ...

    May 1, 2020, 00:00 AM

  • PIH53 PHARMACISTS' INTERVENTIONS IN TRANSITIONS OF CARE: EVALUATING THE FINANCIAL AND CLINICAL IMPLICATIONS FOR LONG-TERM CARE

    May 1, 2020, 00:00 AM

  • Multiple Diseases - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • CC2 COST-EFFECTIVENESS ANALYSIS OF NEWBORN SCREENING AND TREATMENT FOR SPINAL MUSCULAR ATROPHY

    May 1, 2020, 00:00 AM

  • PDB42 BUDGET IMPACT ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00 AM

  • PIN70 COST OF BLOOD AND BODY FLUID OCCUPATIONAL EXPOSURE MANAGEMENT IN CHINA

    May 1, 2020, 00:00 AM

  • Alternative Medicine Nutrition - Medical Technologies

    May 1, 2020, 00:00 AM

  • PMH56 FITTING ITEM RESPONSE THEORY MODEL TO DETERMINE THE PSYCHOMETRIC PROPERTIES OF KESSLER PSYCHOLOGICAL DISTRESS SCALE AMONG WOMEN WHO EXCHANGE SEX

    May 1, 2020, 00:00 AM

  • PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY

    May 1, 2020, 00:00 AM

  • PGI23 TREATMENT COST ANALYSIS FOR PATIENTS IN THE UNITED STATES WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS WHO HAVE AN INADEQUATE RESPONSE OR WHO ARE INTOLERANT TO TNF BLOCKERS

    May 1, 2020, 00:00 AM

  • Drugs Generics - Organizational Practices

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • PDG63 FACTORS ASSOCIATED WITH SLEEPING MEDICATION USE AMONG ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIN56 VACCINE EXPOSURE DURING PREGNANCY AMONG PRIVATELY AND PUBLICLY INSURED WOMEN IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIH42 RECURRENT VAGINITIS AND CANDIDIASIS: BURDEN AMONG COMMERCIALLY INSURED WOMEN WITH TYPE II DIABETES IN THE US

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • PB2 ADHERENCE TO INJECTABLE ANTIDIABETIC THERAPIES (IAT) AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA: RESULTS FROM A CROSS-SECTIONAL SURVEY STUDY

    May 1, 2020, 00:00 AM

  • PMS95 RHEUMATOID ARTHRITIS TREATMENT PROFILE IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2020, 00:00 AM

  • PIH47 DEMENTIA SEVERITY AND OPIOID USE IN LONG-TERM CARE NURSING HOME RESIDENTS

    May 1, 2020, 00:00 AM

  • Injury Regulatory

    May 1, 2020, 00:00 AM

  • PMD28 PERIOPERATIVE OUTCOME COMPARISON FOLLOWING UNILATERAL AND SIMULTANEOUS BILATERAL TOTAL KNEE ARTHROPLASTY

    May 1, 2020, 00:00 AM

  • PIN14 UPDATING THE CMS MAJOR DIAGNOSTIC CATEGORIES (MDC) TO ALIGN WITH A PATHOPHYSIOLOGICAL MODEL OF DISEASE: IMPLICATIONS FOR RESEARCH AND CLINICAL CARE RESOURCE ALLOCATION

    May 1, 2020, 00:00 AM

  • PMS58 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE ELBOW AND FOREARM BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PDG67 PREDICTORS OF CHRONIC MEDICATION NONADHERENCE IN CANCER SURVIVORS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • PDG7 COST-EFFECTIVENESS ANALYSIS OF SULODEXIDE VERSUS DIOSMIN IN THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY IN CHINA

    May 1, 2020, 00:00 AM

  • Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing

    May 1, 2020, 00:00 AM

  • PIH10 COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA

    May 1, 2020, 00:00 AM

  • PMD31 IS A SUPERFICIAL INFECTION AN INDEPENDENT PREDICTOR FOR A LATER DEEP INCISIONAL INFECTION IN TOTAL KNEE ARTHROPLASTY?

    May 1, 2020, 00:00 AM

  • PIH44 EPIDEMIOLOGICAL DISEASE BURDEN OF FEMALE INFERTILITY BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PDB24 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES MELLITUS WITH NEUROLOGICAL COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00 AM

  • PCV56 COMPARISON OF THE FRAMINGHAM, PROCAM AND MODIFIED FRAMINGHAM RISK SCORES FOR PREDICTING CARDIOVASCULAR EVENTS IN A COHORT FROM A CARDIOVASCULAR PREVENTION PROGRAM IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PBI34 IMPACTS OF LONG-TERM UNCERTAINTY AND FAMILY SPILLOVER EFFECTS ON THE COST-UTILITY OF APPROVED TREATMENTS FOR SMA TYPE I

    May 1, 2020, 00:00 AM

  • Individual's Health - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • PMU8 EVALUATION OF THE IMPACT OF AN INPATIENT DISCHARGE CARE PLANNING INTERVENTION ON HOSPITAL 30-DAY READMISSIONS AND COSTS IN A MEDICARE POPULATION

    May 1, 2020, 00:00 AM

  • PIN57 UPTAKE OF PRE-EXPOSURE PROPHYLAXIS (PREP) AND TYPE OF PROVIDERS AMONG COMMERCIALLY-INSURED PERSONS IN THE UNITED STATES, 2012-2018

    May 1, 2020, 00:00 AM

  • Alternative Medicine Nutrition - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PMD54 COMPARISON OF WOUND CLOSURE IN PRESSURE ULCERS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PDG56 APPLICATION OF HEALTH TECHNOLOGY ASSESSMENT IN CHINA NATIONAL REIMBURSEMENT DRUG LIST PRICE NEGOTIATIONS: THE EVOLVING TREND AND IMPLICATIONS

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • PIN90 COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM

    May 1, 2020, 00:00 AM

  • PMH46 GEOGRAPHIC VARIATION IN TREATMENT ADMISSIONS FOR OPIOID USE DISORDER IN CINCINNATI COMPARED TO THE UNITED STATES

    May 1, 2020, 00:00 AM

  • Alternative Medicine Nutrition - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PDB12 EFFICACY AND SAFETY OF ETELCALCETIDE IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PDG29 DROSPIRENONE INDUCED GALL BLADDER DISEASES: A RETROSPECTIVE STUDY OF EUDRAVIGILANCE DATABASE

    May 1, 2020, 00:00 AM

  • PMS7 THE ROLE OF SPECIALIZED PRO-RESOLVING LIPID MEDIATORS IN THE TREATMENT OF INFLAMMATION CAUSED BY EXERCISING: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PIN8 HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOLLOWING TENOFOVIR ALAFENAMIDE (TAF) APPROVAL

    May 1, 2020, 00:00 AM

  • PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS

    May 1, 2020, 00:00 AM

  • PIH20 OUTCOME AND ECONOMIC EVALUATION OF NEONATAL SCREENING USING MS/MS FOR INHERITED METABOLIC DISEASES

    May 1, 2020, 00:00 AM

  • PIN20 SOCIETAL PRODUCTIVITY GAINS FROM NEW THERAPIES IN HEPATITIS C

    May 1, 2020, 00:00 AM

  • PMS25 CLINICAL VALIDATION OF A BUDGET IMPACT MODEL USING THE ESTABLISHED KEY OPINION LEADER VALIDATION FRAMEWORK (KOLVF)

    May 1, 2020, 00:00 AM

  • Individual's Health - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • Multiple Diseases - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • Medical Devices - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • PDG15 ECONOMIC ASSESSMENT OF SWITCHING FROM DIPEPTIDYL PEPTIDASE-4 INHIBITORS TO SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS OR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USING REAL-WORLD DATA

    May 1, 2020, 00:00 AM

  • PMD5 COMPARATIVE EFFECTIVENESS ASSESSMENT OF TWO POWERED SURGICAL STAPLING PLATFORMS IN LAPAROSCOPIC SLEEVE GASTRECTOMY

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • Mental Health - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • PIN36 BUDGETARY IMPACT ANALYSIS OF PREEXPOSURE PROPHYLAXIS (PREP) STRATEGY FOR THE PREVENTION OF HIV IN COLOMBIA, 2019-2021

    May 1, 2020, 00:00 AM

  • PDG40 TRENDS IN UTILIZATION, REIMBURSEMENT, AND PRICE FOR ANTICOAGULANTS IN THE US MEDICAID POPULATION FROM 2000 TO 2018

    May 1, 2020, 00:00 AM

  • PDB93 NAFLD SIMULATOR: A WEB-BASED SIMULATION TOOL TO PREDICT LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE

    May 1, 2020, 00:00 AM

  • PIH58 GEOGRAPHICAL DISPARITIES IN NON-UTILIZATION OF HEALTH FACILITY DELIVERY AND POSTNATAL SERVICES IN GHANA

    May 1, 2020, 00:00 AM

  • PDG10 COST-EFFECTIVENESS OF CELECOXIB VERSUS IBUPROFEN AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS IN UNITED ARAB EMIRATES AND SAUDI ARABIA BASED ON RESULTS FROM THE PRECISION TRIAL

    May 1, 2020, 00:00 AM

  • PDB75 EFFECT OF CHRONIC EXPOSURE TO PSYCHOTROPIC MEDICATION ON THE INCIDENCE OF NEW-ONSET TYPE 2 DIABETES MELLITUS IN ADULTS, A RETROSPECTIVE COHORT STUDY USING PRESCRIPTION CLAIMS FROM COLOMBIA

    May 1, 2020, 00:00 AM

  • PMH35 MENTAL AND BEHAVIORAL DISORDERS DUE TO OPIOID USE IN COLOMBIA: PREVALENCE AND DEMOGRAPHIC CHARACTERISTICS 2009-2018

    May 1, 2020, 00:00 AM

  • PMH12 TRAJECTORY IN HYPNOTIC DRUG USE, SELF-PERCEIVED HEALTH, AND HEALTHCARE EXPENDITURES AMONG PATIENTS DIAGNOSED WITH ANXIETY DISORDERS

    May 1, 2020, 00:00 AM

  • PIN35 UTILIZATION, SPENDING AND PRICE TRENDS FOR ANTIVIRAL (FLU AGENTS) IN THE US MEDICAID PROGRAMS: EMPIRICAL DATA ANALYSIS FROM 1999-2018.

    May 1, 2020, 00:00 AM

  • Mental Health - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PIH4 NUMBER NEEDED TO TREAT (NNT) WITH FENFLURAMINE TO ACHIEVE A CLINICALLY MEANINGFUL REDUCTION IN CONVULSIVE SEIZURE FREQUENCY IN PATIENTS WITH DRAVET SYNDROME: HEALTH ECONOMIC IMPLICATIONS

    May 1, 2020, 00:00 AM

  • PDB68 CHARACTERISTICS OF PATIENTS WITH SEVERE HYPOGLYCEMIA AMONG PATIENTS WITH DIABETES USING INSULIN IN COMMERCIALLY INSURED, MEDICARE, AND MEDICAID POPULATION

    May 1, 2020, 00:00 AM

  • PIH36 TIME TO CONFIRMATORY TESTING OF CHILDREN AGE 72 MONTHS FOR ELEVATED BLOOD LEAD

    May 1, 2020, 00:00 AM

  • PIH21 EFFICACY AND SAFETY OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN PATIENTS WITH OSTEOARTHRITIS: A NETWORK META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PCV68 PREDICTORS OF FAILURE-TO-RESCUE FOR ACUTE MYOCARDIAL INFARCTION

    May 1, 2020, 00:00 AM

  • PMD32 RISK AND OUTCOMES FOLLOWING APPLICATION OF MULTI-PLANAR RING FIXATION SYSTEMS - A TWELVE YEAR REVIEW FROM A US CLAIMS DATABASE ANALYSIS

    May 1, 2020, 00:00 AM

  • PMU7 IS THE TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION FIT-FOR-PURPOSE?: A MIXED-METHODS APPROACH

    May 1, 2020, 00:00 AM

  • PGI36 ESTIMATION OF THE MINIMAL IMPORTANT DIFFERENCES IN EUROQOL-5 DIMENSIONS (EQ-5D) FOR PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION

    May 1, 2020, 00:00 AM

  • PDB69 FACTORS ASSOCIATED WITH PRE-DIABETES IN THE U.S ‘DIABETES-BELT’ REGION POPULATION

    May 1, 2020, 00:00 AM

  • PIH31 INVERSE RELATIONSHIP BETWEEN ANEMIA IN THE THIRD TRIMESTER OF PREGNANCY AND LOW BIRTH WEIGHT IN A REFERENCE MATERNITY UNIT OF A CARRIBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PMD45 COMPARISON OF WOUND CLOSURE IN CHRONIC LOWER EXTREMITY ULCERS BETWEEN SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY AND TRADITIONAL NEGATIVE PRESSURE WOUND THERAPY: A REAL WORLD ANALYSIS

    May 1, 2020, 00:00 AM

  • PMS40 REAL-WORLD TREATMENT PATTERNS AND ECONOMIC BURDEN OF ROTATOR CUFF TEAR PATIENTS IN THE US

    May 1, 2020, 00:00 AM

  • PMH8 EFFECT OF DEPRESSION ON WORK PRODUCTIVITY COSTS AND EMPLOYMENT

    May 1, 2020, 00:00 AM

  • PMU11 ASSOCIATION BETWEEN DEPRESSION AND HEALTHCARE EXPENDITURES AMONG STROKE SURVIVORS

    May 1, 2020, 00:00 AM

  • PDG57 EFFICACY AND SAFETY OF FLAVONOIDS IN ADULT PATIENTS WITH HEMORRHOIDS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING

    May 1, 2020, 00:00 AM

  • PMU20 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A UNITED STATES ANALYSIS

    May 1, 2020, 00:00 AM

  • PMS52 EPIDEMIOLOGY OF DERMATITIS ATOPIC IN AMERICA: SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

    May 1, 2020, 00:00 AM

  • PIH35 LONG-TERM PRESCRIPTION OPIOID USE AMONG OLDER ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • Advanced Analytics Studies

    May 1, 2020, 00:00 AM

  • PMU39 COOKING AT HOME CAN SAVE MONEY, REGARDLESS OF FOOD PRICE: A MULTILEVEL ANALYSIS OF MEALS PREPARED AWAY FROM THE HOME ON DIET MEASURES AND FOOD EXPENDITURES

    May 1, 2020, 00:00 AM

  • PIH63 THE EFFICACY OF TREATMENTS FOR ATOPIC DERMATITIS IN CHILDREN: A NETWORK META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PDG47 OUTPATIENT OPIOID PRESCRIBING AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF NATIONAL AMBULATORY MEDICAL CARE SURVEY, 2011-2016

    May 1, 2020, 00:00 AM

  • PGI21 COST PER ACCEPTABLE LIFE-YEARS AND COST PER QALY GAINS IN NON-ACCEPTABLE HEALTH STATE FOR BIOLOGICAL TREATMENT IN CROHN'S DISEASE, A NOVEL APPROACH IN HEALTH ECONOMIC MODELLING

    May 1, 2020, 00:00 AM

  • PCN15 EFFICACY, EFFECTIVENESS, AND SAFETY OF FRONTLINE TREATMENTS FOR PERIPHERAL T-CELL LYMPHOMA

    May 1, 2020, 00:00 AM

  • PMU45 FACTORS ASSOCIATED WITH NEGATIVE SELF RATED HEALTH (SRH) IN A PRIVATE HEALTH PLAN IN BRAZIL

    May 1, 2020, 00:00 AM

  • PMU65 EVALUATION OF HOME HEALTH FOR PATIENTS ELIGIBLE FOR THE POST-ACUTE CARE TRANSFER POLICY

    May 1, 2020, 00:00 AM

  • Individual's Health - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PIN19 A COST EFFECTIVENESS ANALYSIS OF ACTIVE CASE FINDING AND PASSIVE CASE FINDING FOR CASE DETECTION OF TUBERCULOSIS AT KISUGU HC III,KAMPALA UGANDA.

    May 1, 2020, 00:00 AM

  • PDG14 BUDGET IMPACT ANALYSIS OF GIPAP AND VPAP TERMINATION WITHIN THE NEXT 5 YEARS IN VIETNAM

    May 1, 2020, 00:00 AM

  • PDG41 CLOSURE OF THE PART D COVERAGE GAP AND OUT-OF-POCKET COSTS FOR RHEUMATOID ARTHRITIS BIOLOGICS IN MEDICARE PART D

    May 1, 2020, 00:00 AM

  • Editorial Board

    Apr 21, 2020, 08:38 AM

  • Public Attitudes on Lung Cancer Screening and Radiation Risk: A Best-Worst Experiment

    Apr 1, 2020, 00:00 AM

  • Is There a Future for Value-Based Contracting? [Editor's Choice]

    Apr 1, 2020, 00:00 AM

  • A Systematic Review of the Feasibility and Psychometric Properties of the ICEpop CAPability Measure for Adults and Its Use So Far in Economic Evaluation

    Apr 1, 2020, 00:00 AM

  • Are Value-Based Arrangements the Answer We’ve Been Waiting for?

    Apr 1, 2020, 00:00 AM

  • Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report [Editor's Choice]

    Apr 1, 2020, 00:00 AM

  • Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications

    Apr 1, 2020, 00:00 AM

  • Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts

    Apr 1, 2020, 00:00 AM

  • Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France

    Apr 1, 2020, 00:00 AM

  • Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match? [Editor's Choice]

    Apr 1, 2020, 00:00 AM

  • Table of Contents

    Apr 1, 2020, 00:00 AM

  • Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users

    Apr 1, 2020, 00:00 AM

  • Biosimilar Uptake in Medicare Part B Varied Across Hospital Outpatient Departments and Physician Practices: The Case of Filgrastim

    Apr 1, 2020, 00:00 AM

  • Reporting Quality of Discrete Event Simulations in Healthcare—Results From a Generic Reporting Checklist

    Apr 1, 2020, 00:00 AM

  • Copyright/Subscription

    Apr 1, 2020, 00:00 AM

  • Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

    Apr 1, 2020, 00:00 AM

  • Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma

    Apr 1, 2020, 00:00 AM

  • Managed Entry Agreements: Policy Analysis From the European Perspective [Editor's Choice]

    Apr 1, 2020, 00:00 AM

  • Editorial Board

    Mar 18, 2020, 10:02 AM

  • Author's Reply

    Mar 1, 2020, 00:00 AM

  • Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis

    Mar 1, 2020, 00:00 AM

  • Socioeconomic Status of Newborns and Hospital Efficiency: Implications for Hospital Payment Methods

    Mar 1, 2020, 00:00 AM

  • How Are Debriefing Questions Used in Health Discrete Choice Experiments? An Online Survey

    Mar 1, 2020, 00:00 AM

  • Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis

    Mar 1, 2020, 00:00 AM

  • Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?

    Mar 1, 2020, 00:00 AM

  • Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting [Editor's Choice]

    Mar 1, 2020, 00:00 AM

  • Measuring Quality-Adjusted Life-Years When Health Fluctuates

    Mar 1, 2020, 00:00 AM

  • Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation

    Mar 1, 2020, 00:00 AM

  • Table of Contents

    Mar 1, 2020, 00:00 AM

  • Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs [Editor's Choice]

    Mar 1, 2020, 00:00 AM

  • Moving Beyond the Tip of the Iceberg to Incorporate Patients’ Perspectives and Outcomes in the Medical Device Regulatory Process

    Mar 1, 2020, 00:00 AM

  • A Step Closer to Better Research Prioritization? The ISPOR Value of Information Task Force Reports

    Mar 1, 2020, 00:00 AM

  • Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms–Constipation Using Phase IIb Clinical Trial Data

    Mar 1, 2020, 00:00 AM

  • Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force [Editor's Choice]

    Mar 1, 2020, 00:00 AM

  • Computing PROPr Utility Scores for PROMIS® Profile Instruments

    Mar 1, 2020, 00:00 AM

  • Letter to the Editor: Methods for Measuring Multiple Medication Adherence: A Systematic Review

    Mar 1, 2020, 00:00 AM

  • Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information

    Mar 1, 2020, 00:00 AM

  • Subscription Page

    Mar 1, 2020, 00:00 AM

  • Economic Evaluation of User-Fee Exemption Policies for Maternal Healthcare in Burkina Faso: Evidence From a Cost-Effectiveness Analysis

    Mar 1, 2020, 00:00 AM

  • Exploratory Factor Analysis of a Patient-Centered Cancer Care Measure to Support Improved Assessment of Patients’ Experiences

    Mar 1, 2020, 00:00 AM

  • Editorial Board

    Feb 27, 2020, 10:34 AM

  • Health-Related Quality of Life in Children With Low Language or Congenital Hearing Loss, as Measured by the PedsQL and Health Utility Index Mark 3

    Feb 1, 2020, 00:00 AM

  • Value-Based Pharmaceutical Contracts: Value for Whom?

    Feb 1, 2020, 00:00 AM

  • Copyright/Subscription

    Feb 1, 2020, 00:00 AM

  • Why Reinvent the Wheel? Use or Modification of Existing Clinical Outcome Assessment Tools in Medical Product Development [Editor's Choice]

    Feb 1, 2020, 00:00 AM

  • Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus

    Feb 1, 2020, 00:00 AM

  • “Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval

    Feb 1, 2020, 00:00 AM

  • Table of Contents

    Feb 1, 2020, 00:00 AM

  • Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana

    Feb 1, 2020, 00:00 AM

  • Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example

    Feb 1, 2020, 00:00 AM

  • To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland

    Feb 1, 2020, 00:00 AM

  • Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation

    Feb 1, 2020, 00:00 AM

  • Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems [Editor's Choice]

    Feb 1, 2020, 00:00 AM

  • Optimal Design of Population-Level Financial Incentives of Influenza Vaccination for the Elderly

    Feb 1, 2020, 00:00 AM

  • A Head-On Ordinal Comparison of the Composite Time Trade-Off and the Better-Than-Dead Method

    Feb 1, 2020, 00:00 AM

  • Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force

    Feb 1, 2020, 00:00 AM

  • Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study

    Feb 1, 2020, 00:00 AM

  • What Difference Does It Make? A Comparison of Health State Preferences Elicited From the General Population and From People With Multiple Sclerosis

    Feb 1, 2020, 00:00 AM

  • Effects of Lean Healthcare on Patient Flow: A Systematic Review

    Feb 1, 2020, 00:00 AM

  • Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions [Editor's Choice]

    Feb 1, 2020, 00:00 AM

  • Author's Reply

    Feb 1, 2020, 00:00 AM

  • Editorial Board

    Jan 15, 2020, 08:20 AM

  • Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary

    Jan 1, 2020, 00:00 AM

  • Economic Evaluation of Systemic Treatments for Advanced Melanoma: A Systematic Review

    Jan 1, 2020, 00:00 AM

  • Copyright/Subscription

    Jan 1, 2020, 00:00 AM

  • Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations

    Jan 1, 2020, 00:00 AM

  • Cost-Effectiveness of RAS Genetic Testing Strategies in Patients With Metastatic Colorectal Cancer: A Systematic Review

    Jan 1, 2020, 00:00 AM

  • Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System

    Jan 1, 2020, 00:00 AM

  • Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis [Editor's Choice]

    Jan 1, 2020, 00:00 AM

  • A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C

    Jan 1, 2020, 00:00 AM

  • Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention

    Jan 1, 2020, 00:00 AM

  • Costs and Benefits of Alternative Strategies to Control the Spread of Livestock-Acquired Methicillin-Resistant Staphylococcus Aureus From Pig Production

    Jan 1, 2020, 00:00 AM

  • HTA Around the World: Broadening Our Understanding of Cross-Country Differences [Editor's Choice]

    Jan 1, 2020, 00:00 AM

  • Table of Contents

    Jan 1, 2020, 00:00 AM

  • Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts’ Perspectives

    Jan 1, 2020, 00:00 AM

  • Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis [Editor's Choice]

    Jan 1, 2020, 00:00 AM

  • Increasing the Legitimacy of Tough Choices in Healthcare Reimbursement: Approach and Results of a Citizen Forum in The Netherlands

    Jan 1, 2020, 00:00 AM

  • Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?

    Jan 1, 2020, 00:00 AM

  • The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review

    Jan 1, 2020, 00:00 AM

  • Development of System Performance Indicators for Adolescent and Young Adult Cancer Care and Control in Canada

    Jan 1, 2020, 00:00 AM

  • Disclosure Information

    Dec 17, 2019, 09:25 AM

  • Editorial Board

    Dec 3, 2019, 08:15 AM

  • Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study

    Dec 1, 2019, 00:00 AM

  • Table of Contents

    Dec 1, 2019, 00:00 AM

  • Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model

    Dec 1, 2019, 00:00 AM

  • Measuring Productivity Costs in Patients With Musculoskeletal Disorders: Measurement Properties of the Institute for Medical Technology Assessment Productivity Cost Questionnaire

    Dec 1, 2019, 00:00 AM

  • Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis

    Dec 1, 2019, 00:00 AM

  • How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L [Editor's Choice]

    Dec 1, 2019, 00:00 AM

  • Excess Costs and Economic Burden of Obesity-Related Cancers in the United States [Editor's Choice]

    Dec 1, 2019, 00:00 AM

  • Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis

    Dec 1, 2019, 00:00 AM

  • Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses

    Dec 1, 2019, 00:00 AM

  • Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial

    Dec 1, 2019, 00:00 AM

  • Equity Weights for Priority Setting in Healthcare: Severity, Age, or Both?

    Dec 1, 2019, 00:00 AM

  • Copyright/Subscription

    Dec 1, 2019, 00:00 AM

  • Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments? [Editor's Choice]

    Dec 1, 2019, 00:00 AM

  • Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017

    Dec 1, 2019, 00:00 AM

  • Carer Social Care-Related Quality of Life Outcomes: Estimating English Preference Weights for the Adult Social Care Outcomes Toolkit for Carers

    Dec 1, 2019, 00:00 AM

  • Cost-Effectiveness of Antihypertensive Therapy in Patients Older Than 80 Years: Cohort Study and Markov Model

    Dec 1, 2019, 00:00 AM

  • Editorial Board

    Nov 13, 2019, 17:52 PM

  • CC2 ECONOMIC ASSESSMENT OF A HIGH DOSE VERSUS A STANDARD DOSE INFLUENZA VACCINE IN THE US VETERAN POPULATION: ESTIMATING THE IMPACT ON HOSPITALIZATION COST FOR CARDIOVASCULAR AND RESPIRATORY DISEASE

    Nov 1, 2019, 00:00 AM

  • PCN178 MODELLING THE BUDGET IMPACT OF INTRODUCING 3D MAMMOGRAPHY FOR BREAST CANCER SCREENING IN GERMANY

    Nov 1, 2019, 00:00 AM

  • PCN103 A COMPARISON OF PARTITIONED-SURVIVAL AND STATE TRANSITION MODELLING APPROACHES - FINDINGS FROM A CASE STUDY IN ONCOLOGY

    Nov 1, 2019, 00:00 AM

  • PIH61 VALIDATION OF THE STUDY MEDICATION SATISFACTION QUESTIONNAIRE (SMSQ). A MEASURE OF MEDICATION SATISFACTION DESIGNED FOR INDIVIDUALS TAKING PRE-EXPOSURE PROPHYLAXIS (PREP) MEDICATION FOR HIV

    Nov 1, 2019, 00:00 AM

  • PMD19 ECONOMIC EVALUATION OF CATARACT PHACOEMULSIFICATION IN THE RUSSIAN FEDERATION

    Nov 1, 2019, 00:00 AM

  • PDB57 COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN

    Nov 1, 2019, 00:00 AM

  • PDB52 ECONOMIC BURDEN ASSOCIATED WITH DIABETIC RETINOPATHY: EVIDENCE FROM A LITERATURE REVIEW

    Nov 1, 2019, 00:00 AM

  • PMU4 WHAT IS A GOOD OR BAD NUMBER NEED TO TREAT (NNT) VALUE? A LITERATURE REVIEW

    Nov 1, 2019, 00:00 AM

  • PRO115 DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

    Nov 1, 2019, 00:00 AM

  • PCV73 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS WARFARIN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN THE JAPANESE HEALTHCARE SETTING

    Nov 1, 2019, 00:00 AM

  • PCV152 SELF-ASSESSED FUNCTIONAL CLASS, QUALITY OF LIFE AND HEALTHCARE RESOURCE CONSUMPTION IN PORTUGUESE HEART FAILURE PATIENTS: AN ANALYSIS OF THE PRIME STUDY

    Nov 1, 2019, 00:00 AM

  • PNS182 SYSTEMIC ADMINISTRATION OF GLUCOCORTICOIDS IN GUIZHOU PROVINCE, CHINA: A SURVEY AMONG HOSPITAL PHARMACIES.

    Nov 1, 2019, 00:00 AM

  • PMU100 A SYSTEMATIC REVIEW OF PREVIOUSLY PUBLISHED OR APPRAISED HEALTH ECONOMIC ESTIMATING THE SHORT- AND LONG-TERM CONSEQUENCES OF STEROID-SPARING AGENTS

    Nov 1, 2019, 00:00 AM

  • Musculoskeletal Disorders - Health Policy Regulatory

    Nov 1, 2019, 00:00 AM

  • PMU29 ECONOMIC EVALUATION FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURES INFECTIONS (ABSSSI) FROM THE NATIONAL PAYER PERSPECTIVE: INTRODUCTION OF A NEW TREATMENT INTO THE PATIENT JOURNEY. SIMULATION IN 3 EUROPEAN COUNTRIES

    Nov 1, 2019, 00:00 AM

  • PIH56 PLACE OF COMPLEMENTARY MEDICINES AND OPPORTUNITIES IN THE MANAGEMENT OF GYNECOLOGICAL CANCER PATIENTS

    Nov 1, 2019, 00:00 AM

  • PUK9 MEDICO-ECONOMIC EVALUATION OF HAEMODIAFILTRATION IN COMPARISON TO HIGH FLUX DIALYSIS

    Nov 1, 2019, 00:00 AM

  • PCV104 A SYSTEMATIC REVIEW OF ORGANISATIONAL AND SERVICE SPECIFICATION RECOMMENDATIONS FOR CENTRES PROVIDING PERCUTANEOUS CORONARY INTERVENTIONS

    Nov 1, 2019, 00:00 AM

  • PCN370 IMPROVING PATIENT ACCESS TO INNOVATIVE MEDICATIONS WHILE PROTECTING PUBLIC BUDGETS SUSTAINABILITY: AN ALTERNATIVE GO TO MARKET AND PRICING FRAMEWORK TO ENABLE VALUE CO-CREATION BETWEEN PHARMAS AND PAYERS

    Nov 1, 2019, 00:00 AM

  • PCN80 REAL-WORLD HEALTHCARE COSTS IN PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER IN ITALY

    Nov 1, 2019, 00:00 AM

  • PNS311 PREDICTIVE-ADJUSTED INDIRECT COMPARISON (PAIC): A NOVEL METHOD FOR POPULATION-ADJUSTED INDIRECT COMPARISON

    Nov 1, 2019, 00:00 AM

  • PCV6 BURDEN OF MORTALITY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION - A LITERATURE REVIEW

    Nov 1, 2019, 00:00 AM

  • PCN43 NEW CERVICAL CANCER SCREENING POLICY IN GERMANY - WHAT IS THE IMPACT ON THE BENEFIT-HARM BALANCE?

    Nov 1, 2019, 00:00 AM

  • PDB15 THE COST OF HYPOGLYCAEMIA IN TYPE 2 DIABETES MELLITUS IN THE NETHERLANDS

    Nov 1, 2019, 00:00 AM

  • PNS140 POTENTIAL IMPACTS OF THE U.K. VOLUNTARY SCHEME FOR BRANDED MEDICINES PRICING AND ACCESS: A REVIEW OF STAKEHOLDER OPINION

    Nov 1, 2019, 00:00 AM

  • PDG74 AN ANALYSIS OF RESTRICTED RECOMMENDATIONS BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

    Nov 1, 2019, 00:00 AM

  • PMU50 UNFOLD THE MYSTERY OF PRICE NEGOTIATION IN CHINA: HOW REIMBURSEMENT PAYMENT STANDARD WAS FORMULATED

    Nov 1, 2019, 00:00 AM

  • PGI10 COST-UTILITY ANALYSIS OF USTEKINUMAB VS VEDOLIZUMAB IN CROHN DISEASE IN ITALY

    Nov 1, 2019, 00:00 AM

  • PDB72 DEPRIVATION - MAIN CAUSE OF DIABETIC FOOT ULCER IN GERMANY

    Nov 1, 2019, 00:00 AM

  • PIH40 ASSESSING HEALTH DISPARITY IN THE ELDERLY POPULATION WITH DIFFERENT ECONOMIC STATUS IN SOUTH KOREA: FOCUSING ON HIP FRACTURE

    Nov 1, 2019, 00:00 AM

  • PCV141 ATHEROSCLEROSIS: REAL-WORLD INSIGHTS FROM A PORTUGUESE PRIMARY CARE DATABASE

    Nov 1, 2019, 00:00 AM

  • PCN68 BRENTUXIMAB VEDOTIN FOR CONSOLIDATION THERAPY AFTER ASCT IN CD30+ HODGKIN'S LYMPHOMA: A SUSTAINABLE PHARMACEUTICAL EXPENDITURE FOR THE ITALIAN NATIONAL HEALTH SERVICE

    Nov 1, 2019, 00:00 AM

  • PCN193 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH PLATINUM CHEMOTHERAPY AND PEMETREXED FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND

    Nov 1, 2019, 00:00 AM

  • PMU139 VALIDITY OF THE SLOVENIAN VERSION OF THE CARERQOL-7D QUESTIONNAIRE AMONG INFORMAL CAREGIVERS IN THE SLOVENIAN GENERAL POPULATION

    Nov 1, 2019, 00:00 AM

  • Alternative Medicine Nutrition - Economic Evaluation

    Nov 1, 2019, 00:00 AM

  • PIN130 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME/AVIBACTAM FOR THE TREATMENT OF ADULTS WITH COMPLICATED URINARY TRACT INFECTIONS IN BULGARIA

    Nov 1, 2019, 00:00 AM

  • PMU43 A MORE ACCURATE MEASURE OF AFFORDABILITY OF ALCOHOL FOR THE RUSSIAN FEDERATION

    Nov 1, 2019, 00:00 AM

  • PCN96 COST-EFFECTIVENESS OF TREATMENT SEQUENCES FOR BRAF WILD-TYPE METASTATIC MELANOMA IN REAL LIFE IN FRANCE

    Nov 1, 2019, 00:00 AM

  • PBI24 SECUKINUMAB VS ADALIMUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: A COST PER RESPONDER ANALYSIS AT 52 WEEKS FROM AN ALGERIAN PERSPECTIVE

    Nov 1, 2019, 00:00 AM

  • PNS347 SCIENTIFIC OUTCOME OF ISPOR CONFERENCES: AN ANALYSIS OF 44,390 ABSTRACTS PRESENTED AT 38 ISPOR CONFERENCES BETWEEN 2002-2018

    Nov 1, 2019, 00:00 AM

  • Alternative Medicine Nutrition - Patient-Centered Research

    Nov 1, 2019, 00:00 AM

  • PNS370 METHODS AND CONSIDERATIONS FOR THE DEVELOPMENT, CONTENT VALIDITY TESTING, AND EVALUATION OF PATIENT EDUCATION TOOLS (PETS)

    Nov 1, 2019, 00:00 AM

  • PIN115 ANALYZING SOCIO-ECONOMIC INEQUALITY IN CHILDHOOD IMMUNIZATION COVERAGE IN ETHIOPIA

    Nov 1, 2019, 00:00 AM

  • PUK12 ANALYSIS OF COST AND CONSEQUENCES RELATED TO THE PERSISTENCE OF MIRABEGRON AND ANTIMUSCARINIC TREATMENTS AND THEIR IMPACT ON QUALITY OF LIFE IN PATIENTS AGED ≥ 65 YEARS WITH OVERACTIVE BLADDER IN SPAIN

    Nov 1, 2019, 00:00 AM

  • PR4 TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION (TSQM - VERSION 1.4): CEILING AND FLOOR EFFECTS, RELIABILITY AND CONSTRUCT VALIDITY

    Nov 1, 2019, 00:00 AM

  • PNS290 EVIDENCE-BASED VALUE FRAMEWORK FOR THE EVALUATION OF CLINICAL PHARMACY SERVICES

    Nov 1, 2019, 00:00 AM

  • PSU34 COMPLICATIONS AND REIMBURSEMENT AMONG PATIENTS WITH HAMMERTOE SURGERY: A MEDICARE SUPPLEMENTAL DATABASE STUDY WITH TWO YEARS FOLLOW-UP

    Nov 1, 2019, 00:00 AM

  • PCN244 BUDGETARY IMPACT OF VENETOCLAX WITH RITUXIMAB VERSUS IBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Nov 1, 2019, 00:00 AM

  • PCN284 PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN NON-SMALL CELL LUNG CANCER IN IRELAND

    Nov 1, 2019, 00:00 AM

  • PMH13 SYSTEMATIC REVIEW OF UTILITY VALUES USED IN THE PHARMACOECONOMIC EVALUATIONS FOR SCHIZOPHRENIA: IMPLICATIONS ON COST-EFFECTIVENESS RESULTS

    Nov 1, 2019, 00:00 AM

  • PNS53 REVIEW OF METHODOLOGICAL QUALITY OF BUDGET IMPACT ANALYSES FOR ORPHAN DRUGS

    Nov 1, 2019, 00:00 AM

  • PDB123 CURRENT STATUS AND USE OF RESOURCES OF LYSOSOMAL STORAGE DISEASES: ANALYSIS OF A SPANISH CLAIMS DATABASE

    Nov 1, 2019, 00:00 AM

  • PNS91 ACCESS AND UTILIZATION OF MATERNAL HEALTHCARE IN A RURAL DISTRICT IN THE FOREST BELT OF GHANA

    Nov 1, 2019, 00:00 AM

  • PDG18 COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT IN TREATING NAMD IN CHINA

    Nov 1, 2019, 00:00 AM

  • PMS59 REAL-WORLD EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTIONS FOR MUSCULOSKELETAL DISORDERS IN NIGERIA

    Nov 1, 2019, 00:00 AM

  • PRS48 UNLOCKING THE ACCESS CHALLENGES TO COPD

    Nov 1, 2019, 00:00 AM

  • PRS21 PRODUCTIVITY LOSSES FOR ALLERGIC RHINITIS PATIENTS IN THE NETHERLANDS AND SWEDEN

    Nov 1, 2019, 00:00 AM

  • PDB35 COST-EFFECTIVENESS OF GLICLAZIDE MR-BASED INTENSIVE GLUCOSE CONTROL VERSUS STANDARD GLUCOSE CONTROL IN TYPE 2 DIABETES MELLITUS. AN ECONOMIC ANALYSIS IN VIETNAM OF THE ADVANCE TRIAL

    Nov 1, 2019, 00:00 AM

  • Urinary/Kidney Disorders - Health Service Delivery Process of Care

    Nov 1, 2019, 00:00 AM

  • PRS71 NEW METHODS FOR ANALYZING CLINICAL AND COST OUTCOMES IN ASTHMA WITH INTERACTIVE VISUAL ANALYTICS

    Nov 1, 2019, 00:00 AM

  • PNS57 BUDGET IMPACT ANALYSIS OF A WEARABLE REMOTE CONTINUOUS MONITORING DEVICE TO FACILITATE EARLY DISCHARGE OF BARIATRIC SURGERY PATIENTS IMMEDIATELY AFTER POSTOPERATIVE OBSERVATION IN THE RECOVERY WARD

    Nov 1, 2019, 00:00 AM

  • PCN139 BUDGET IMPACT ANALYSIS OF NILOTINIB AS FIRST LINE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) WITH HIGH RISK SOKAL SCORE IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Nov 1, 2019, 00:00 AM

  • PNS109 PERCEPTIONS AND PRACTICES OF SELF- MEDICATION IN AN INDIAN URBAN COMMUNITY

    Nov 1, 2019, 00:00 AM

  • PNS371 EVALUATING QUALITY OF PRIMARY HEALTH CARE (PHC) SERVICES FROM THE PATIENTS' PERSPECTIVE IN GREECE

    Nov 1, 2019, 00:00 AM

  • PCN338 KEY DRIVERS OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR RELAPSED-REFRACTORY MULTIPLE MYELOMA TREATMENTS; A COUNTRY COMPARISON.

    Nov 1, 2019, 00:00 AM

  • PCN293 POST-PROGRESSION ENDPOINTS IN ONCOLOGY TRIALS: CURRENT CLINICAL AND REIMBURSEMENT PERSPECTIVES

    Nov 1, 2019, 00:00 AM

  • PMU68 THE ROLE OF OUTCOMES-BASED MODELS FOR THE REIMBURSEMENT OF MEDICINES IN THE UK NATIONAL HEALTH SERVICE

    Nov 1, 2019, 00:00 AM

  • PPM6 HEALTH ECONOMICS MODEL OF FOUNDATIONONE CDX® IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN TURKEY

    Nov 1, 2019, 00:00 AM

  • PSU40 PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE AFTER TOTAL JOINT REPLACEMENT: A SYSTEMATIC LITERATURE REVIEW

    Nov 1, 2019, 00:00 AM

  • PR3 HOME-BASED ASSESSMENT OF PATIENT REPORTED OUTCOME MEASURES USING A SMARTPHONE APP PLATFORM: A FEASIBILITY STUDY

    Nov 1, 2019, 00:00 AM

  • PIN44 COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINATION IN THE DUTCH NATIONAL INFLUENZA PREVENTION PROGRAM

    Nov 1, 2019, 00:00 AM

  • PCN153 OVERVIEW OF ECONOMIC EVALUATIONS OF ONCOLOGY PRODUCTS WITH A FOCUS ON THE KEY CHALLENGES ACROSS, UNITED KINGDOM, FRANCE AND CANADA

    Nov 1, 2019, 00:00 AM

  • PAM15 PHOTOGRAPHIC FOOD DIARIES FOR NUTRITIONAL RESEARCH WITH CHILDREN AND HARD-TO-REACH POPULATIONS: A CASE STUDY EXPLORATION OF A NOVEL ASSESSMENT TOOL

    Nov 1, 2019, 00:00 AM

  • PCN16 ASSESSMENT OF THE QUALITY OF LIFE, PHYSICAL ACTIVITY, DEPRESSION AND ANXIETY OF PATIENTS UNDER ONCOLOGY CARE

    Nov 1, 2019, 00:00 AM

  • PDB76 IMPACT OF COPAYMENT INCREASE OF ANTIDIABETIC MEDICATIONS ON GLYCAEMIC CONTROL IN FINNISH PATIENTS WITH TYPE 2 DIABETES

    Nov 1, 2019, 00:00 AM

  • PUK39 URINARY TRACT INFECTIONS (UTIS) AFTER UROGENITAL PROCEDURES AND RELATED OUTCOMES AND COSTS: ANALYSIS OF DATA FROM THE NATIONAL HOSPITAL INFORMATION SYSTEM

    Nov 1, 2019, 00:00 AM

  • Alternative Medicine Nutrition - Clinical Outcomes

    Nov 1, 2019, 00:00 AM

  • PNS273 ICER: SIMILARITIES AND DIFFERENCES BETWEEN UK (ENGLAND) AND USA COST-EFFECTIVENESS WATCHDOGS

    Nov 1, 2019, 00:00 AM

  • PRO10 QUALITATIVE STUDY TO ESTABLISH THE CONTENT VALIDITY OF THE ABC-CFXS FOR EVALUATION OF TREATMENT EFFICACY IN FRAGILE X SYNDROME

    Nov 1, 2019, 00:00 AM

  • PIN14 HEALTH UTILITY ESTIMATES FOR CONGENITAL CYTOMEGALOVIRUS DISEASE: CONCEPTUAL DESIGN CONSIDERATIONS

    Nov 1, 2019, 00:00 AM

  • PNS350 ANALYSIS OF HEALTH CARE WORKERS' MIGRATION: THE MOTIVATIONS OF HUNGARIAN PHISIOTHERAPISTS FOR WORKING ABROAD

    Nov 1, 2019, 00:00 AM

  • PMS52 CLINICAL GUIDELINE DEVELOPMENT FOR THE MANAGEMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN PRIMARY CARE

    Nov 1, 2019, 00:00 AM

  • PCV46 BUDGET IMPACT OF A DUAL-LAYER STENT RETRIEVER (DLSR) IN THE TREATMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE (AIS) FROM HOSPITAL'S PERSPECTIVE IN FRANCE AND SWEDEN

    Nov 1, 2019, 00:00 AM

  • PRO3 TREATMENT PATTERNS AND OUTCOMES ASSOCIATED WITH THE USE OF PONATINIB IN CLINICAL PRACTICE: A QUALITATIVE SYSTEMATIC LITERATURE REVIEW

    Nov 1, 2019, 00:00 AM

  • PCN411 HOW ARE SINGLE-ARM TRIALS PERCEIVED IN HEATH TECHNOLOGY ASSESSMENTS FOR CHRONIC LEUKAEMIA ACROSS THE EU5, AUSTRALIA AND CANADA?

    Nov 1, 2019, 00:00 AM

  • PNS291 ANALYSIS OF RECALLS OF MEDICAL DEVICES FROM 2009 TO 2018 BY RISK CLASS AND DEVICE CATEGORY BASED ON ITALIAN DATA

    Nov 1, 2019, 00:00 AM

  • PMU87 REVIEW OF ORPHAN TREATMENTS ASSESSED BY NICE AND THE SMC IN THE UK.

    Nov 1, 2019, 00:00 AM

  • Drugs Generics - Health Technology Assessment

    Nov 1, 2019, 00:00 AM

  • PCN234 COST-EFFECTIVENESS ANALYSIS OF HOME-BASED PALLIATIVE CARE FOR END-STAGE CANCER PATIENTS

    Nov 1, 2019, 00:00 AM

  • PRO132 DISEASE BURDEN OF X-LINKED HYPOPHOSPHATEMIA

    Nov 1, 2019, 00:00 AM

  • PBI89 PHARMACOUTILIZATION OF BIOLOGICAL DRUGS IN PATIENTS AFFECTED BY PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS IN AN ITALIAN REAL-WORLD SETTING

    Nov 1, 2019, 00:00 AM

  • PCV99 UNDERSTANDING POST DISCHARGE MANAGEMENT AFTER AN ACUTE MYOCARDIAL INFARCTION IN ITALY: REGIONAL PATHWAYS AND OUTCOME INDEX

    Nov 1, 2019, 00:00 AM
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36 (current)
  • 37
  • 38
  • 39
  • 40
  • »